Decoy Therapeutics Inc. (DCOY) Gross margin 2016–2018
Decoy Therapeutics Inc. (DCOY) gross margin by fiscal year — reported gross profit divided by reported revenue.
77.9%FY2018 · since FY2016: 34.4% → 77.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | 77.9% | +17.7 pp |
| FY2017 | 60.3% | +25.8 pp |
| FY2016 | 34.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More DCOY financial trends
DCOY RevenueDCOY Net incomeDCOY Net marginDCOY Gross profitDCOY Operating incomeDCOY Operating marginDCOY Operating cash flowDCOY Free cash flowDCOY Capital expendituresDCOY Return on equityDCOY Stock buybacksDCOY Dividends paidDCOY Total assetsDCOY Total liabilitiesDCOY Shareholders’ equityDCOY overview →